Proteolipid protein is necessary in peripheral as well as central myelin

被引:111
作者
Garbern, JY
Cambi, F
Tang, XM
Sima, AAF
Vallat, JM
Bosch, EP
Lewis, R
Shy, M
Sohi, J
Kraft, G
Chen, KL
Joshi, I
Leonard, DGB
Johnson, W
Raskind, W
Dlouhy, SR
Pratt, V
Hodes, ME
Bird, T
Kamholz, J
机构
[1] WAYNE STATE UNIV,SCH MED,CTR MOL MED & GENET,DETROIT,MI 48201
[2] WAYNE STATE UNIV,SCH MED,DEPT PATHOL,DETROIT,MI 48201
[3] THOMAS JEFFERSON UNIV,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19107
[4] UNIV HOSP,DEPT NEUROL,F-87042 LIMOGES,FRANCE
[5] MAYO CLIN & MAYO FDN,DEPT NEUROL,SCOTTSDALE,AZ 85259
[6] UNIV WASHINGTON,SCH MED,DEPT PHYS MED & REHABIL,SEATTLE,WA 98195
[7] UNIV WASHINGTON,SCH MED,DEPT MED,DIV MED GENET,SEATTLE,WA 98195
[8] UNIV WASHINGTON,SCH MED,DEPT NEUROL,SEATTLE,WA 98195
[9] UNIV PENN,DEPT PATHOL,MOL DIAGNOST LAB,PHILADELPHIA,PA 19104
[10] ROBERT WOOD JOHNSON MED SCH,DEPT NEUROL,PISCATAWAY,NJ 08854
[11] INDIANA UNIV,SCH MED,DEPT MED & MOL GENET,INDIANAPOLIS,IN 46202
关键词
D O I
10.1016/S0896-6273(00)80360-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alternative products of the proteolipid protein gene (PLP), proteolipid protein (PLP) and DM20, are major components of compact myelin in the central nervous system, but quantitatively minor constituents of Schwann cells, A family with a null allele of PLP has a less severe CNS phenotype than those with other types of PLP mutations. Moreover, individuals with PLP null mutations have a demyelinating peripheral neuropathy, not seen with other PLP mutations of humans or animals. Direct analysis of normal peripheral nerve demonstrates that PLP is localized to compact myelin. This and the clinical and pathologic observations of the PLP null phenotype indicate that PLP/DM20 is necessary for proper myelin function both in the central and peripheral nervous systems.
引用
收藏
页码:205 / 218
页数:14
相关论文
共 81 条
  • [1] PROTEOLIPID PROTEIN AND DM-20 ARE SYNTHESIZED BY SCHWANN-CELLS, PRESENT IN MYELIN MEMBRANE, BUT THEY ARE NOT FATTY ACYLATED
    AGRAWAL, HC
    AGRAWAL, D
    [J]. NEUROCHEMICAL RESEARCH, 1991, 16 (08) : 855 - 858
  • [2] ANDRE M, 1990, J NEURORADIOLOGY, V17, P216
  • [3] [Anonymous], INTRO MOL NEUROBIOLO
  • [4] [Anonymous], 1989, MOL CLONING LAB MANU
  • [5] PROTEIN-KINASE-C ACTIVITY MODULATES MYELIN GENE-EXPRESSION IN ENRICHED OLIGODENDROCYTES
    ASOTRA, K
    MACKLIN, WB
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 1993, 34 (05) : 571 - 588
  • [6] BAER ROBERT D., 1965, ARCH PHYS MED REHABIL, V46, P698
  • [7] CONNEXIN MUTATIONS IN X-LINKED CHARCOT-MARIE-TOOTH DISEASE
    BERGOFFEN, J
    SCHERER, SS
    WANG, S
    SCOTT, MO
    BONE, LJ
    PAUL, DL
    CHEN, K
    LENSCH, MW
    CHANCE, PF
    FISCHBECK, KH
    [J]. SCIENCE, 1993, 262 (5142) : 2039 - 2042
  • [8] SEPARATION OF THE MAJOR PROTEINS OF CENTRAL AND PERIPHERAL NERVOUS-SYSTEM MYELIN USING REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    BIZZOZERO, OA
    ODYKIRK, TS
    MCGARRY, JF
    LEES, MB
    [J]. ANALYTICAL BIOCHEMISTRY, 1989, 180 (01) : 59 - 65
  • [9] BOISON D, 1995, J NEUROSCI, V15, P5502
  • [10] PELIZAEUS-MERZBACHER DISEASE - CLINICAL AND NOSOLOGICAL STUDY
    BOULLOCHE, J
    AICARDI, J
    [J]. JOURNAL OF CHILD NEUROLOGY, 1986, 1 (03) : 233 - 239